LABGENOMICS is involved in the development of next-generation sequencing (NGS) and siRNA therapeutics based on a novel nanoparticle drug delivery system.
LABGENOMICS
Category:
Diagnostics
Main Business Area
Next-generation sequencing (NGS) and siRNA therapeutics
| Contact Details | 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do (Sampyeong-dong, Korea Biopark Building B, 6th floor)TEL.031-628-0702 |
|---|
Find out more companies
Related products
-
DiagnosticsTASCOM (YidoBio)
TASCOM (YidoBio)’s R&D Center focuses on developing cell therapy for the treatment of diabetes with leading scientists working with key doctors in the field. TASCOM (YidoBio) also distributes diabetic and related medical supplies from top manufacturers such as BD, Arkray, and i-SENS.
-
-
-
-
DiagnosticsEYEGENE lnc. LTD
EYEGENE Inc. is a clinical-stage biopharmaceutical company developing vaccines and new innovative recombinant protein drugs.